ADHD is a neurodevelopmental disorder characterized by a persistent pattern of inattention and/or hyperactivity/impulsivity that interferes with functioning and/or development.1 ADHD can have a profound impact on an individual’s life, causing disruption at school, work, home, and in relationships.
According to Centers for Disease Control and Prevention, approximately 8.8% of school-aged children (ages 6 to 17) in the United States, or approximately 5.7 million people, have been diagnosed with ADHD in their lifetime.2, 3 It is estimated that 4.4% of adults in the United States (or approximately 10.5 million people) are estimated to struggle with ADHD.2, 3 Current ADHD treatment guidelines recommend a multi-faceted approach that uses medications in conjunction with behavioral interventions.2 In 2018, approximately 72 million prescriptions were written for ADHD,4 which generated nearly $9 billion in gross sales.5 Approximately 91% of these prescriptions were for stimulant medications such as amphetamine and methylphenidate.4
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington, VA: American Psychiatric Association; 2013.
- 2016 National Survey of Children’s Health (US-NSCH) https://www.cdc.gov/ncbddd/adhd/data.html. Accessed September 10, 2019.
- Brus ML, et al. J. Psychiatr Pract. 2014; (6):428-37. 2016 National Survey of Children’s Health (US-NSCH) https://www.nimh.nih.gov/health/statistics/attention-deficit-hyperactivity-disorder-adhd.shtml. Accessed September 10, 2019.
- IQVIA: National Prescription Audit – trailing 12 month data as of March 2019.
- IQVIA; National Sales Perspective – trailing 12 month data as of March 2019.